依达拉奉联合银杏达莫治疗急性脑梗死的临床观察

目的:探讨依达拉奉与银杏达莫联用治疗急性脑梗死的临床疗效。方法:将105例急性脑梗死患者随机分为两组,对照组38例予银杏达莫注射液20mL,每日1次静脉滴注,连续14d;治疗组67例在对照组基础上联用依达拉奉,每次30mL,连续14d。于治疗前和治疗后分别进行神经功能缺损程度评分,并判定临床疗效。结果:治疗组治疗后神经功能缺损评分明显降低,与治疗前比较差异有统计学意义(P<0.01),治疗组显效率、总有效率与对照组比较差异均有统计学意义(P<0.05),治疗组优于对照组。结论:依达拉奉与银杏达莫联用治疗急性脑梗死可有效终止病情进展,改善神经功能缺损,提高临床疗效。

Clinical Observe the Therapeutic Effect of Edaravone Injection with Yinxingdamo Injection on Acut Cerebral Infarction

Objective：To observe the therapeutic effect of Edaravone injection with Yinxingdamo injection on acut cerebral infarction. Methods：105 patients with acut cerebral infarction were randomly divided into two groups. 38 patients in control group, on the basis of routine treatment, were treated by Yinxingdamo injection 20 mL once a day, with a treatment course of 14 days. The other 67 patients in treatment group, on the basis of control group, were treated by Edaravone injection 30mL once a day, with a treatment course of 14 days. The scoring of nervous function defect before treatment and after treatment were conducted, and the therapeutic effects were evaluated in both groups. Results：The scorings of nervous function defect in treatment group after treatment were significantly decreased, compared with those before treatment （P 〈0.01）,The therapeutic effect of treatment group was superior to that of control group, there were significant differences in effective rate and total effective rate between treatment group and control group （P 〈0.05）.Conclusion：The Edaravone injection with Yinxingdamo injection is effective in treating acut cerebral infarction, which can delay the progression of state of illness effectively, improve nervous function defect and enhance therapeutic effect.